News | February 07, 2022
Serum receives green light for Omicron variant vaccine
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Pfizer and Moderna are also working on vaccines that target the Omicron variant
This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older
First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose
The country is sixth among the most affected countries by active cases
An article by a team of 12 Italian and 9 Russian scientists led by Francesco Vaia, Director of the Spallanzani Institute and Alexander Gintsburg, Director of the Gamaleya Center, has been published in medRxiv
It provides Covid-19 detection and Omicron surveillance in less than two hours
In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants
The study will be published on the pre-print server, medRXiv, shortly
Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
Subscribe To Our Newsletter & Stay Updated
